# MIMic-study
Scripts for analyzing 16S rRNA gene sequencing data derived from MIMic trial (NCT03772899) - a multicenter single-arm phase I safety trial that included patients with advanced cutaneous melanoma who were being treated with first-line anti-PD-1 therapy. 
